This paper concentrates on the primary theme of Financial Statement Analysiss in which you have to explain and evaluate its intricate aspects in detail. In addition to this, this paper has been reviewed and purchased by most of the students hence; it has been rated 4.8 points on the scale of 5 points. Besides, the price of this paper starts from £ 79. For more details and full access to the paper, please refer to the site.

I built the common-size and percentage-change financial statements (attached) but I am not certain if I am drawing the correct conclusions. Would like some help with summarizing the results of the financial statement analysis by evaluating the following questions:

-How do ICN and Merck compare in their profitability and risk?
-On what factors are they similar or significantly different?
-Of the different forecasted scenarios, which do you believe is most likely for ICN and Merck?